MedTrace Logo

Examining HIV Treatment Adherence During Early Disease

NCT02419066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 904

Last updated 2018-08-16

No results posted yet for this study

Summary

Determine the level, patterns, and correlates of objectively measured ART adherence in early and advanced-stage disease, among pregnant and non-pregnant individuals, to determine the need and nature of interventions to support early ART adherence in Uganda and South Africa

Conditions

  • Medication Adherence
  • HIV

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Mbarara University of Science and Technology

    collaborator OTHER

  • Desmond Tutu HIV Centre

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Jessica Haberer, MD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • South Africa
  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02419066 on ClinicalTrials.gov